Search results
Results from the WOW.Com Content Network
He was born in Xinhua County, Loudi City, Hunan, in 1984. [10]He Jiankui attended the University of Science and Technology of China for undergraduate studies from 2002 to 2006, and graduated with a major in modern physics in 2006. [10]
The He Jiankui genome editing incident is a scientific and bioethical controversy concerning the use of genome editing following its first use on humans by Chinese scientist He Jiankui, who edited the genomes of human embryos in 2018.
Make People Better is a 2022 documentary film about the use of genetic engineering (called CRISPR gene editing) to enhance two twins girls to be immune to HIV.Directed by Cody Sheehy of Rhumbline Media, it was originated by Samira Kiani, a biotechnologist then at Arizona State University. [1]
He Jiankui, the Chinese scientist who sparked global outrage in 2018 when he revealed that he had created the first gene-edited children, has put forward a new proposal for modifying human embryos ...
He eventually received widespread international condemnation. He Jiankui, working at the Southern University of Science and Technology (SUSTech) in Shenzhen, China, started a project to help people with HIV-related fertility problems, specifically involving HIV-positive fathers and HIV-negative mothers.
The section on human genetic augmentation features a stern-faced bioethicist woman demanding more global regulations to prevent people like He Jiankui working outside institutions.
He Jiankui (China), former associate professor with the Southern University of Science and Technology, was in 2019 sentenced to three years in prison and fined three million yuan (about US$430,000) for illegally carrying out human embryo gene-editing intended for reproduction. [79] The case is called the He Jiankui affair. [80] [81]
The creation of HIV-resistant babies by Chinese researcher He Jiankui is perhaps the most famous example of gene disruption using this method. [68] It is far less effective at gene correction. Methods of base editing are under development in which a “nuclease-dead” Cas 9 endonuclease or a related enzyme is used for gene targeting while a ...